Disparities Among Liver Transplant Patients
Recruiting
Observational Study
End Stage Liver DIsease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- Patients with end-stage liver, kidney, or cardiac dysfunction.
Exclusion Criteria:
* Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.
* Patients with potential medical exclusions fo…
Contacts
Gabrielle Montefiore
480-574-1288
CONTACT